JP2011514139A5 - - Google Patents

Download PDF

Info

Publication number
JP2011514139A5
JP2011514139A5 JP2010523277A JP2010523277A JP2011514139A5 JP 2011514139 A5 JP2011514139 A5 JP 2011514139A5 JP 2010523277 A JP2010523277 A JP 2010523277A JP 2010523277 A JP2010523277 A JP 2010523277A JP 2011514139 A5 JP2011514139 A5 JP 2011514139A5
Authority
JP
Japan
Prior art keywords
antibody
polyclonal
cell line
individual
rsv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010523277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011514139A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2008/050218 external-priority patent/WO2009030237A2/en
Publication of JP2011514139A publication Critical patent/JP2011514139A/ja
Publication of JP2011514139A5 publication Critical patent/JP2011514139A5/ja
Pending legal-status Critical Current

Links

JP2010523277A 2007-09-07 2008-09-04 抗rsv抗体の組み換え製造のための方法 Pending JP2011514139A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200701289 2007-09-07
US97140407P 2007-09-11 2007-09-11
PCT/DK2008/050218 WO2009030237A2 (en) 2007-09-07 2008-09-04 Methods for recombinant manufacturing of anti-rsv antibodies

Publications (2)

Publication Number Publication Date
JP2011514139A JP2011514139A (ja) 2011-05-06
JP2011514139A5 true JP2011514139A5 (enExample) 2012-11-08

Family

ID=40297785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523277A Pending JP2011514139A (ja) 2007-09-07 2008-09-04 抗rsv抗体の組み換え製造のための方法

Country Status (13)

Country Link
US (2) US20090137003A1 (enExample)
EP (1) EP2185590A2 (enExample)
JP (1) JP2011514139A (enExample)
KR (1) KR20100087283A (enExample)
CN (1) CN101821289A (enExample)
AU (1) AU2008295248A1 (enExample)
BR (1) BRPI0817079A2 (enExample)
CA (1) CA2695309A1 (enExample)
MX (1) MX2010002044A (enExample)
RU (1) RU2010113510A (enExample)
TW (1) TW200925279A (enExample)
WO (1) WO2009030237A2 (enExample)
ZA (1) ZA201000756B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3231442B1 (en) * 2006-06-23 2019-12-25 ADC Therapeutics SA Polynucleotides and polypeptide sequences involved in cancer
RU2459868C2 (ru) * 2007-03-01 2012-08-27 Симфоген А/С Способ клонирования когнатных антител
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
EP2331689A4 (en) * 2008-08-29 2012-10-31 Symphogen As METHOD OF CLONING AVIAN ORIGIN ANTIBODIES
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
JP5762408B2 (ja) 2009-08-13 2015-08-12 クルセル ホランド ベー ヴェー ヒト呼吸器合胞体ウイルス(rsv)に対する抗体および使用方法
KR101789343B1 (ko) * 2009-10-06 2017-10-23 메드임뮨 리미티드 Rsv-특이적 결합 분자
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CN104628850B (zh) * 2009-10-06 2020-07-28 医学免疫有限公司 Rsv-特异性结合分子
MY172472A (en) 2009-12-10 2019-11-26 Regeneron Pharma Mice that make heavy chain antibodies
TWI539963B (zh) 2010-07-09 2016-07-01 庫賽爾荷蘭公司 抗-人類呼吸道融合性病毒(rsv)抗體及其使用方法
PL3173427T3 (pl) 2011-03-31 2019-11-29 Adc Therapeutics Sa Przeciwciała przeciwko antygenowi związanemu z nerkami 1 i ich fragmenty wiążące antygen
AU2013209234B2 (en) 2012-01-09 2017-11-09 Adc Therapeutics Sa Method for treating breast cancer
KR102355959B1 (ko) * 2012-08-23 2022-01-27 어젠시스 인코포레이티드 158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트(adc)
JP5996707B2 (ja) * 2015-04-15 2016-09-21 メディミューン リミテド Rsv特異的結合分子
TWI716405B (zh) 2015-05-07 2021-01-21 美商艾吉納斯公司 抗ox40抗體及其使用方法
MA43389A (fr) * 2015-12-02 2021-05-12 Agenus Inc Anticorps anti-ox40 et leurs procédés d'utilisation
WO2017096182A1 (en) * 2015-12-03 2017-06-08 Agenus Inc. Anti-ox40 antibodies and methods of use thereof
CN110035771B (zh) 2016-10-21 2024-03-08 阿迪马布有限责任公司 抗呼吸道合胞病毒抗体及其产生和使用方法
WO2018075954A2 (en) 2016-10-21 2018-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
CA3040893A1 (en) 2016-10-21 2018-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
WO2018089628A1 (en) 2016-11-09 2018-05-17 Agenus Inc. Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereof
WO2018150029A1 (en) * 2017-02-17 2018-08-23 Institut Pasteur Generation of monoclonal antibodies targeting respiratory syncytial virus (rsv) using regulatory b cells from newborns (nbregs)
WO2021202463A1 (en) 2020-03-30 2021-10-07 Danisco Us Inc Anti-rsv antibodies
CA3177152A1 (en) 2020-06-12 2021-12-16 David Scott Johnson Recombinant polyclonal proteins targeting covid-19 and methods of use thereof
WO2022031834A1 (en) * 2020-08-05 2022-02-10 Gigagen, Inc. Recombinant polyclonal proteins targeting zika and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
ES2332524T3 (es) * 2004-07-20 2010-02-08 Symphogen A/S Un procedimiento para la caracterizacion de una linea celular policlonal.
BRPI0513706A (pt) * 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
JP2009518320A (ja) * 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
AU2007222798A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
CN101679513A (zh) * 2007-03-06 2010-03-24 西福根有限公司 用于治疗呼吸道合胞病毒感染的重组抗体
EP2152872B1 (en) * 2007-05-25 2010-09-15 Symphogen A/S Method for manufacturing a recombinant polyclonal protein

Similar Documents

Publication Publication Date Title
JP2011514139A5 (enExample)
JP2010535012A5 (enExample)
JP2014534242A5 (enExample)
JP2022061992A5 (enExample)
JP2016196468A5 (enExample)
JP2013063981A5 (enExample)
JP2020124209A5 (enExample)
JP2020122013A5 (enExample)
JP2015504306A5 (enExample)
RU2010113510A (ru) Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv)
JP2016511750A5 (enExample)
JP2019500862A5 (enExample)
JP2019006820A (ja) 多重特異性多価抗体の生成方法
JP2013545438A5 (enExample)
FI2155783T4 (fi) Lajien välisesti spesifinen cd3-epsilon-sitoutumisdomeeni
Konwarh Nanobodies: prospects of expanding the gamut of neutralizing antibodies against the novel coronavirus, SARS-CoV-2
JP2010500876A5 (enExample)
RU2014136103A (ru) Антагонистические антитела против рецептора IL-7 и способы
JP2018504105A5 (enExample)
JP2010511388A5 (enExample)
JP2011527902A5 (enExample)
JP2016536322A5 (enExample)
JP2011527899A5 (enExample)
JP2019523221A5 (enExample)
HRP20191983T1 (hr) Konstrukti protutijela za cdh19 i cd3